{"nct_id":"NCT00063141","title":"Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer","status":"COMPLETED","status_verified_date":"2010-04","start_date":"2003-04","start_date_type":null,"primary_completion_date":"2006-06","primary_completion_date_type":"ACTUAL","completion_date":"2007-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}